Skip to main contentSkip to navigation
Sirius Investors
Gene Biotherapeutics, Inc.

Gene Biotherapeutics, Inc.

CRXM
OTCHealthcare

Insider Trading for CRXM

View recent insider trading activity including purchases, sales, and awards. Insider trading can provide insights into how executives view their company's prospects.

Insider Trading Summary

Shares Acquired
Sign in to see amounts
Shares Disposed
Sign in to see amounts
Net Position
Sign in to see net activity
Unlock for free

Already registered? Sign in

Recent Activity (30 Days)

No insider transactions in the past 30 days.

Quarterly Activity (3 Months)

No insider transactions in the past 3 months.

Key Insider Activity: Feb 28, 2014 to Mar 31, 2021

Jemapete Christopher J
Other10 Percent Owner:
+500.0K shares
4 transactions
HUTCHISON MURRAY H
DirectorDirector
+100.0K shares
2 transactions
Leitch Andrew M
DirectorDirector
+100.0K shares
2 transactions
MULROY DENNIS
ExecutiveCorporate Officer
+50.0K shares
1 transactions

Transaction Details

DateInsiderRoleTransactionSharesPriceValueOwned AfterSEC Filing
Mar 31, 2021Jemapete Christopher J10 Percent Owner: Unknown0$0.00$0.000View
Mar 17, 2021Jemapete Christopher J10 Percent OwnerPurchase200.0K$0.40$80,400.004.0MView
Mar 16, 2021Jemapete Christopher J10 Percent OwnerPurchase300.0K$0.04$11,970.003.8MView
Feb 26, 2021
Locked
Mar 23, 2015
Locked
Mar 23, 2015
Locked
Feb 28, 2014
Locked
Feb 28, 2014
Locked
Feb 28, 2014
Locked
Click "View" in the SEC Filing column to access the detailed SEC form submission for each transaction.

Executive Activity:

Executives have been net buyers of CRXM stock, which is typically a strong positive signal.